Peretz T - Search Results

1

Ex-vivo organ culture as potential prioritization tool for breast cancer targeted therapy.

Grinshpun A, Gavert N, Granit RZ, Masuri H, Ben-Porath I, Breuer S, Zick A, Rosenberg S, Maoz M, Granit A, Pikarsky E, Straussman R, Peretz T, Sonnenblick A. Grinshpun A, et al. Among authors: peretz t. Cancer Biol Ther. 2018 Aug 3;19(8):645-648. doi: 10.1080/15384047.2018.1450114. Epub 2018 Apr 13. Cancer Biol Ther. 2018. PMID: 29565707 Free PMC article.

2

The involvement of thrombin RGD in metastasis: characterization of a cryptic adhesive site.

Bar-Shavit R, Ginzburg Y, Maoz M, Vlodavsky I, Peretz T. Bar-Shavit R, et al. Among authors: peretz t. Isr J Med Sci. 1995 Feb-Mar;31(2-3):86-94. Isr J Med Sci. 1995. PMID: 7744600

3

Bone marrow metastases in breast cancer.

Pikarsky E, Peretz T. Pikarsky E, et al. Among authors: peretz t. N Engl J Med. 2000 Aug 24;343(8):577-8. N Engl J Med. 2000. PMID: 10979783 No abstract available.

4

Human protease-activated receptor 1 expression in malignant epithelia: a role in invasiveness.

Yin YJ, Salah Z, Grisaru-Granovsky S, Cohen I, Even-Ram SC, Maoz M, Uziely B, Peretz T, Bar-Shavit R. Yin YJ, et al. Among authors: peretz t. Arterioscler Thromb Vasc Biol. 2003 Jun 1;23(6):940-4. doi: 10.1161/01.ATV.0000066878.27340.22. Epub 2003 Mar 13. Arterioscler Thromb Vasc Biol. 2003. PMID: 12637343

5

[Prophylactic oophorectomy among carriers of BRCA1/2 mutations--demographic and pathologic data].

Daum H, Sagi M, Pikarsky E, Pruss D, Hamburger T, Peretz T. Daum H, et al. Among authors: peretz t. Harefuah. 2006 Jan;145(1):13-7, 79-80. Harefuah. 2006. PMID: 16450717 Hebrew.

6

Tamoxifen induces heparanase expression in estrogen receptor-positive breast cancer.

Cohen I, Maly B, Simon I, Meirovitz A, Pikarsky E, Zcharia E, Peretz T, Vlodavsky I, Elkin M. Cohen I, et al. Among authors: peretz t. Clin Cancer Res. 2007 Jul 15;13(14):4069-77. doi: 10.1158/1078-0432.CCR-06-2546. Clin Cancer Res. 2007. PMID: 17634531

7

Function of heparanase in prostate tumorigenesis: potential for therapy.

Lerner I, Baraz L, Pikarsky E, Meirovitz A, Edovitsky E, Peretz T, Vlodavsky I, Elkin M. Lerner I, et al. Among authors: peretz t. Clin Cancer Res. 2008 Feb 1;14(3):668-76. doi: 10.1158/1078-0432.CCR-07-1866. Epub 2008 Jan 22. Clin Cancer Res. 2008. PMID: 18212251

8

p53 controls hPar1 function and expression.

Salah Z, Haupt S, Maoz M, Baraz L, Rotter V, Peretz T, Haupt Y, Bar-Shavit R. Salah Z, et al. Among authors: peretz t. Oncogene. 2008 Nov 20;27(54):6866-74. doi: 10.1038/onc.2008.324. Epub 2008 Sep 29. Oncogene. 2008. PMID: 18820708

9

Response to neo-adjuvant chemotherapy in BRCA1 and BRCA2 related stage III breast cancer.

Hubert A, Mali B, Hamburger T, Rottenberg Y, Uziely B, Peretz T, Kadouri L. Hubert A, et al. Among authors: peretz t. Fam Cancer. 2009;8(3):173-7. doi: 10.1007/s10689-008-9223-7. Epub 2008 Nov 19. Fam Cancer. 2009. PMID: 19016350

10

Effects of the single nucleotide polymorphism at MDM2 309 on breast cancer patients with/without BRCA1/2 mutations.

Nechushtan H, Hamburger T, Mendelson S, Kadouri L, Sharon N, Pikarsky E, Peretz T. Nechushtan H, et al. Among authors: peretz t. BMC Cancer. 2009 Feb 18;9:60. doi: 10.1186/1471-2407-9-60. BMC Cancer. 2009. PMID: 19226467 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

325 results

Search Page